Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2010 Financial Results on Wednesday, February 10th, at 4:30 P.M. EST
(Feb 08, 2010)
ELND005 Phase II Study for Alzheimer's disease
Patient Enrollment Information on TT223 + GLP-1 Analogue Phase Ib for Type 2 Diabetes
